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Abstract. Mass gatherings pose a risk for tuberculosis (TB) transmission and reactivation of latent TB infection. The
annual Hajj pilgrimage attracts 2 million pilgrims many from high TB-endemic countries. We evaluated the burden of
undiagnosedactive pulmonary TB inpilgrimsattending the2015Hajjmassgathering.Weconducted aprospective cross-
sectional study in Mecca, Kingdom of Saudi Arabia, for nonhospitalized adult pilgrims from ﬁve high TB-endemic
countries. Enrollment criteria were the presence of a cough and the ability to produce a sputum sample. Sputum samples
were processedusing the XpertMTB-RIF assay. Datawere analyzed for drug-resistant TB, risk factors, and comorbidities
by the country of origin. Of 1,164 consenting pilgrims enrolled from ﬁve countries: Afghanistan (316), Bangladesh (222),
Nigeria (176), Pakistan (302), and South Africa (148), laboratory results were available for 1,063 (91.3%). Themean age of
pilgrims was 54.5 (range = 18–94 years) with a male to female ratio of 2.6:1; 27.7% had an underlying comorbidity, with
hypertension and diabetes being the most common, 20% were smokers, and 2.8% gave a history of previous TB
treatment. Fifteen pilgrims (1.4%) had active previously undiagnosed drug-sensitive pulmonary TB (Afghanistan [12;
80%], Pakistan [2; 13.3%], andNigeria [1; 6.7%]). Nomultidrug-resistant TB caseswere detected. Pilgrims from high TB-
endemic Asian and African countries with undiagnosed active pulmonary TB pose a risk to other pilgrims from over 180
countries. Further studies are required to deﬁne the scale of the TB problem during the Hajj mass gathering and the
development of proactive screening, treatment and prevention guidelines.
INTRODUCTION
Tuberculosis (TB) remains a global public health problem
with signiﬁcant morbidity and mortality. In 2015, the World
Health Organisation (WHO) estimated that 10.4 million people
developed active TB of whom 480,000 developed multidrug-
resistant TB (MDR-TB) with additional 100,000 cases of
rifampicin-resistant TB (RR-TB).1 Mortality from TB in 2015
reached 1.8 million, making it one of the top ten causes of
death worldwide.1,2
International travel, mass gathering events, and migration
facilitate the spread of TB. In this context, the Kingdom of
Saudi Arabia (KSA) is particularly relevant because of its
hosting of the Hajj, where annually around 2 million pilgrims
from over 180 countries visit KSA. Many of these pilgrims are
elderly, have underlying health conditions, and originate from
high TB-endemic countries. Living together in close proximity
during the Hajj may facilitate TB transmission including TB
from pilgrims with active pulmonary TB.3 There is a large
burden of undiagnosed TB in high TB-endemic countries.1
Pilgrims are not screened for TBbefore entry into theKSA, and
it is likely that some may enter the Kingdom with active TB.
Because respiratory tract infections and cough are common
among pilgrims,4 patients are often diagnosed with upper
respiratory tract infections and only those requiring hospital-
isation may be thoroughly investigated.3 Pilgrims infected
during Hajj may also spread the infection to contacts in their
countries including potential MDR strains.
Scanty data are available on the prevalence of active TB
during Hajj, and there have been no speciﬁc studies to deﬁne
the burden of TB during the pilgrimage.2 Evidence of TB in
pilgrims comes from clinical studies of causes of hospital
admissions during Hajj which reported the isolation ofMyco-
bacterium tuberculosis from 5% to 28% of patients with
pneumonia during the event.2,5 Given the short duration of the
Hajj pilgrimage, these active TB cases are likely to be either
imported or reactivated.3 We conducted a cross-sectional
study to evaluate the burden of undiagnosed active pulmo-
nary TB in pilgrims arriving in the KSA for the 2015 Hajj.
MATERIALS AND METHODS
Study population and setting. The study was a pro-
spective cross-sectional design study conducted in Mecca,
KSA, over a 2-week period from September 14 to 29, 2015
(1–15 Dhul Hijja 1436H in the Islamic calendar). The study
enrolled 1,164 consenting nonhospitalized adult pilgrims
(> 18 years of age) who had cough and could voluntarily
produce sputum samples. Pilgrims were selected from ﬁve
countries in Africa and South Asia and chosen because they
are endemic to TB, have high MDR/RR-TB rates, and large
pilgrims’ population (Table 1).
Data and samples collection. Pilgrims were enrolled at
their place of residenceduring theHajj. Face to face interviews
and review of pilgrims’ entry documents were used to ﬁll in
study questionnaires designed to collect data regarding pil-
grims’ contact information, demographics, and TB risk fac-
tors. Sputumsampleswere collected in sterile containers from
each pilgrim and maintained in cold conditions (2–8C) until
storage at −80C for later processing.
Samples processing. All sputum samples were processed
after Hajj at the Saudi National TB Laboratory (Riyadh, KSA)
using the WHO-endorsed Xpert MTB/RIF assay for the rapid
diagnosis of TB and MDR-TB as described previously.6
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Data analysis. Characteristics of the study population
were summarized as frequencies and percentages for qual-
itative variables and as means, range, and standard deviations
(SDs) for quantitative variables. The association between de-
mographic variables and TB was evaluated by χ2 test or
Fisher’s exact test as appropriate. In addition, odds ratios
(ORs) and their CIs were calculated. Multiple logistic re-
gression analysis, using penalized likelihood (Firth method),
was performed to examine the potential impact of the vari-
ables thatwere identiﬁedasbeing signiﬁcantwithP£0.1 in the
univariate analysis. A Stata ado program written by Coveney
(2015)wasused to ﬁt themultiple logistic regressionmodel. All
other tests for signiﬁcancewere two-sidedandP values<0.05
were considered statistically signiﬁcant. All analyses were
done using the SPSS 22.0 (SPSS Inc., Chicago, IL) software
program.
Ethics approval and consent to participate. The study
was approved by the King Fahad Medical City Ethics Com-
mittee and the Institutional Review Board. All participants
gave verbal consent before enrolment, and the study was
conducted in accordance with the Ethics Committee’s
guidelines.
RESULTS
The study enrolled 1,164 pilgrims originating from ﬁve TB-
endemic countries in Africa and South Asia (Table 1). The
characteristics of the study population are summarized in
Table 2. The mean age of pilgrims was 54.5 (SD = 12.1 years,
range = 18–94 years) with a male to female ratio of 2.6:1. Over
half of the respondents had no formal education, and 27.7%
declared having an underlying health condition. Hypertension
and diabetes were the most common comorbidities (Table 3).
A ﬁfth of the respondents declared that they had smoked or
were current smokers of tobacco products such as cigarettes,
cigars, or pipes, and 5.7% had occupations associated with
increased risk of TB infection (Table 2). Travel information in-
dicated that 183 (16.2%) respondents have traveled outside
their country of residence in the previous year visiting coun-
tries in Africa, Asia, the Middle East, Europe, and North
America. The most common destinations visited were Paki-
stan (50.2%), India (13.1%), KSA (8.7%), Malaysia (5.0%), UK
(4.4%), and France (4.4%).While no pilgrim declared that they
were receiving TB treatment at the time of enrolment, 31
(2.8%) revealed that they had been treated for TB in the past,
all of whom conﬁrmed that they had completed their TB
treatment. The latter ranged in duration from 2 to 4 months,
which is shorter than the standard treatment duration for TB,
and may affect persistence of the disease and risk for MDR-
TB. The majority (84%) of those previously treated for TB
originated from Bangladesh.
Xpert MTB/RIF assay results were available for 1,063
(91.3%) of the samples, 15 (1.4%) of which were positive
for TB. No rifampicin resistance was detected in any of the
TABLE 1
Target countries from which pilgrims were enrolled
Country
TB endemicity*
incidence/100,000
population
Prevalence of
MDR/RR-TB*
(% among new cases)
Estimated number
of Hajj pilgrims
in 2015
South Asia
Afghanistan 189 3.9 25,037
Bangladesh 225 1.6 102,795
Pakistan 270 4.2 160,611
Africa
Nigeria 322 4.3 75,212
South Africa 834 3.5 2,435
RR-TB = rifampicin-resistant tuberculosis (TB); MDR-TB = multidrug-resistant TB.
* 2015 data (www.who.int/tb/data).
TABLE 2
Demographic characteristics of the enrolled pilgrims’ population
Variable Number (n) Percentage (%)
Pilgrims enrolled 1,164 –
Gender 1,140 –
Male 823 72.2
Female 317 27.8
Age 1,106 –
Mean (range) 54.5 (18–94) –
£ 47 302 27.3
> 47–55 275 24.9
> 55–64 296 26.8
> 64 233 21.1
Country of residence 1,164 –
Afghanistan 316 27.1
Bangladesh 222 19.1
Nigeria 176 15.1
Pakistan 302 25.9
South Africa 148 12.7
Level of education 1,155 –
No formal education 597 51.7
Primary education 163 14.1
Secondary education 217 18.8
University-higher education 178 15.4
Occupation 1,130 –
Health care worker 34 3.0
Miner 2 0.2
Laboratory personnel 14 1.2
Refugee camp worker 7 0.6
Prison staff 7 0.6
None of the above 1,066 94.3
Underlying health conditions 1,069 –
Yes 296 27.7
No 773 72.3
Pregnancy 1,036 –
Yes 1 0.01
No 1,035 99.9
Tobacco smoker (currently or in the past) 1,145 –
Yes 224 19.6
No 921 80.4
Travel outside current country of
residence in the past year
1,129 –
Yes 183 16.2
No 946 83.8
Recently (pastmonth) lived in a household
with an adult with a cough
1,145 –
Yes 138 12.0
No 1,007 88.0
Any of close contacts ever diagnosed or
treated for TB
1,149 –
Yes 57 5.0
No 768 66.8
Unsure 324 28.2
Currently coughing up blood 1,150 –
Yes 33 2.8
No 1,117 97.2
Ever been treated for TB 1,124 –
Yes 31 2.8
No 961 85.5
Unsure 132 11.7
Currently receiving TB treatment 957 –
Yes 0 0.0
No 957 100
TB = tuberculosis.
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positive samples, hence by proxy no MDR-TB was detected.
The characteristics of pilgrims with positive TB are summa-
rized in Table 4. Most originated from Afghanistan (12, 80%),
were male (10, 66.6%) and had no formal education (13,
86.6%). Their age ranged from 44 to 74 years old and they had
spent 7–23 days in the KSA at the time of enrolment in the
study. Four pilgrims (26.6%) traveled to Pakistan in the pre-
vious year, ﬁve (33.3%) declared having an underlying health
condition but noneworked in one of the TB risk occupations in
the survey. There were no current tobacco smokers among
the TB cases but two (13.3%) had smoked such products
in the past. None of the TB-positive pilgrims declared having a
history of TB themselves or in a close contact.
The result of the univariate analysis showing the association
between TB and demographic variables are summarized in
Table 5 and reveal that only education showed a statistically
signiﬁcant association (P = 0.01). Pilgrims with no formal ed-
ucation were over six times more likely to be TB positive
compared with those with some form of education (primary,
secondary, or higher education) [(OR = 6.17; 95% CI =
1.38–27.4)]. The prevalence of active TB was lowest among
the youngest age group (£ 47 year old) and increasedwith age.
TB prevalence was higher among females, pilgrims residing
in South Asia, those with underlying health conditions, and
those who traveled outside their current country of resi-
dency in the previous year, but the association was not
statistically signiﬁcant for any of these factors. Similarly, no
signiﬁcant association was found between tobacco smok-
ing or recently living in the same household as an adult with
cough and TB.
Only variables found to be signiﬁcant at the 1% level in the
univariate analysis (geographic area of residency and educa-
tion) were considered as candidates for the multiple logistic
regression analysis. Penalized likelihood (Firth method) was
used for the ﬁtting of the logistic regression as the maximum
likelihood estimation of the logistic regression was not ap-
propriate for our studywith sucha small numberof events. The
results indicated that only education was marginally signiﬁ-
cant after adjusting for geographic area of residency (P =
0.052) and that pilgrims with no formal education were nearly
four times more likely to develop active TB than those with
some form of education (adjusted OR = 3.9; 95% CI =
0.98–16.0).
DISCUSSION
Pilgrims attending Hajj maybe at a risk of acquiring TB in-
fection.7 Our study is the ﬁrst to screen Hajj pilgrims with
productive cough for undiagnosed pulmonary TB and has
several important ﬁndings.We found that 1.4%ofHajj pilgrims
with cough from TB-endemic countries had undiagnosed
active TB. This prevalence is within the range found among
migrants to low-incidence countries (0.1–10%),8 yet it means
that potentially 14out of each 1,000pilgrims fromTB-endemic
countries symptomatic for cough could have active TB during
Hajj. This is concerning given that the estimated total number
of pilgrims attending the 2015 Hajj from the WHO’s top 20 TB
burden countries was 1,450,000, and the prevalence of cough
among Hajj pilgrims can reach 80%.4 Considering the short
time pilgrims spent in KSA at the time of enrolment in the
study, it is likely that the identiﬁed active TB cases are im-
ported or reactivation of latent TB infection.3
During the 2015Hajj season, 44 cases of TBamongpilgrims
and residents were diagnosed in Mecca hospitals. We de-
tected active TB among pilgrims symptomatic for cough but
not seriously ill to be hospitalized or require medical atten-
tion and therefore not diagnosed. This is in accordance with
previous TB prevalence surveys which have shown that an
important proportion of infectious individuals with bacterio-
logically positive sputum do not experience symptoms or
symptoms of sufﬁcient severity to prompt health-seeking
behavior.9–11 Also, screening only individuals who meet the
TBscreening criteria of coughover 2 or 3weeksmay result in a
sizable proportion of active TB cases to be missed.
Most (80%) TB cases detected in the study were in pilgrims
from Afghanistan and none were from South Africa. This is
surprising given that among the countries included in the
study, Afghanistan has the lowest TB burden and South Afri-
can has nearly 4.5 times its TB incidence rate.1 Afghanistan is
one of the poorest countries in the world with some of the
lowest indicators of socioeconomic and human development
indices ratings. As a consequence, health services coverage
and delivery, including TB services, may be limited resulting
in TB cases being not diagnosed, notiﬁed, treated, or in
these processes being delayed which leads to persistent
transmission.1,12 In addition, underreporting of TB cases from
the country may also be a factor. The epidemiology of TB in
South Africa is closely related to that of the human immuno-
deﬁciency virus (HIV).13 Most of the Muslim population in
South Africa are of Asian (mostly Indian) descent which rep-
resent around only 2.5%of the population.14 The difference in
the socioeconomic status, behavioural factors, and lower
prevalence of HIV among this ethnic group may also explain
the results observed in our study.14,15
Education was strongly associated with TB prevalence and
pilgrims with no formal education were four times more likely
to have TB. TB is associated with socioeconomic status of
which education is one indicator. Individuals with low socio-
economic status, including low or no education, have higher
TB risk and prevalence, are less likely to seek medical care,
have longer diagnosis delay time, and are at higher risk of
death from TB.16,17 Populations with little or no education are
generally disadvantaged from a social, geographic, or eco-
nomical point of view, all factors that are associated with TB
morbidity and mortality.16 In addition, low education is as-
sociated with poor knowledge of TB and attitude to the
disease, which can facilitate transmission and can lead to
delaying health-seeking behavior, lack of adherence to
treatment regimes, treatment failure and disease compli-
cations, and death.18
TABLE 3
Underlying health conditions among enrolled pilgrims
Underlying health conditions N = 296 Percentage (%)
Hypertension 174 58.8
Diabetes 125 42.2
Chronic kidney disease 6 2.0
Chronic lung disease 13 4.4
Chronic liver disease 7 2.4
Cardiovascular disease 47 15.9
Stroke 1 0.3
Cancer 2 0.7
Immunosuppressive illness 0 0.0
Other 36 12.1
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Worldwide, TB ismore prevalent inmales than females, and
males tend to have higher prevalence of undiagnosed TB than
females.1,9 This is contrary to the results in our study. A pos-
sible explanation for this observation is thatmost (14/15) of the
TB cases in our study were from Afghanistan or Pakistan,
where the prevalence of TB is reported to be higher among
females.1,19 The reportedmale:female TB ratio in Afghanistan,
wheremost of our identiﬁed cases came from, is 0.71, which is
similar to the ratio found in our study.
Underlying health conditions were present among a sizable
number of pilgrims with hypertension and diabetes being the
most common conditions. This is in accordance with other
surveys conducted among Hajj pilgrims.4,20 Although not
statistically signiﬁcant, we found that pilgrims with underlying
health conditions were twice more likely to have TB. Non-
communicable diseases are risk factors for TB,21and there is a
growing awareness of the inﬂuence of TB comorbidity with
these conditions as well as the burden of unsuspected TB.22
Themanagement of noncommunicable disease is essential to
reduce the burden of these diseases during Hajj and could
avoid a signiﬁcant number of TB cases and related deaths.23
As such, the WHO has incorporated the management of
noncommunicable diseases into its End-TB strategy.24
Extremes of age are also risk factors for TB.21 Prevalence of
TB in our study increased with age which is in accordance
with other TB surveys.1,10,11 We found that pilgrims aged
over 64 years were 5.3 times more likely to be TB positive than
those aged 47 years old or less. This is signiﬁcant given that
elderly pilgrims represent a sizable proportion of the Hajj pop-
ulation (roughly 25% are at least 65 years old) and that TB has
been mainly reported in elderly pilgrims during the event.5,25
We found no signiﬁcant association between tobacco
smoking and TB. This is in contrast with the strong evidence
that smoking, active or passive, is signiﬁcantly associated
with increased risks of TB infection and disease, TB trans-
mission, TB mortality, and recurrent TB.26,27 Smoking also
inﬂuences the clinical manifestations and outcomes of TB
adversely affecting baseline disease severity, bacteriological
response, treatment outcome, and relapse in TB and leading
to a faster and more severe progression to TB.27
The results of our study highlight the need formore attention
toward TB and its burden during Hajj, including formulation of
appropriate policies and interventions to prevent infection and
transmission. Such interventions may include increase in
education and awareness regarding TB and its prevention
among pilgrims through targeted campaigns to encourage
health-seeking behavior in case of symptoms and adherence
to treatment and to general infection prevention measures.
There may also be a need for a pre-Hajj TB screening for pil-
grims from certain endemic countries to prevent TB importa-
tion by prompt detection of cases and initiation of effective
treatment before arrival to the KSA. Although under a different
context, TB screening programs are already in effect in a
number of high-income and low-TB incidence countries as
pre-entry requirements for immigrants and were shown to
have the highest impact and be most cost effective if they are
targeted toward arrivals from high TB-endemic countries.8 TB
screening for prevention and control is also implemented in
refugee situations and among displaced populations.28
The introduction of such screening programs for Hajj pil-
grims will require further research and considerations into the
target countries as well as to the practicalities, beneﬁts, and
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cost of such undertakings. These include the establishment,
management, and sustainability of such screening programs
as well as the availability and accessibility to TB health ser-
vices for those identiﬁed to have active TB. Given that most
countries likely to require a pre-Hajj TB screening are also
those with the lowest income and least developed infra-
structures to manage and sustain such screening programs,
international engagement and collaboration, funding, and in-
vestment will be required. Nevertheless, the development
and deployment of new and rapid point-of-care molecular
TB diagnostic technologies, which could be subsidized in
low-income countries to reduce the cost,1 would be most
beneﬁcial.
Our study has some limitations. We only screened 1,164
pilgrims from ﬁve countries which represent only a small
proportion of the Hajj pilgrims’ population. We did not include
some countries with the largest number of Hajj pilgrims such
as Indonesia and India as well as countries with the highest
MDR-TB burden in the world such as the Russian Federation
and many former Soviet Union countries1 which also send
pilgrims to Hajj. Finally, because of cultural and ethical con-
siderations, our study did not collect data on the HIV status or
on alcohol or substance abuse among pilgrims, which are
established risk factors for TB.21
CONCLUSIONS
In summary, we found that a proportion ofHajj pilgrims have
undiagnosed and untreated active TBwhichmay represent an
important source of transmission. In light of these results,
further studies investigating TB during Hajj and the impact of
this mass gathering on TB transmission and epidemiology
worldwide arewarranted. These investigationswill help inform
public health policies and direct interventions for the optimal
awareness, surveillance, screening, treatment and manage-
ment, prevention, andcontrol of TBduringHajj andothermass
gatherings worldwide. TB prevention at Hajj is an important
priority and will go a long way toward achieving the WHO’s
End-TB strategy goals.
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